![A. Davis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: - $ al 31/08/2026
A. Brian Davis is currently an Independent Director at Grace Therapeutics, Inc. since 2023, Chief Financial Officer & IR Contact at Cortendo AB since 2015, and Chief Financial Officer at Xylocor Therapeutics, Inc. since 2021.
Former positions include Controller at MICRO Healthsystems, Inc. from 1991 to 1994, Chief Financial Officer & Senior Vice President at Neose Technologies, Inc. from 1994 to 2010, CFO, Secretary & Senior Vice President-Finance at Tengion, Inc. in 2014, Chief Financial & Accounting Officer at Strongbridge Biopharma Plc from 2015 to 2019, and Chief Financial & Accounting Officer at Verrica Pharmaceuticals, Inc. from 2019 to 2021.
Education includes undergraduate studies at The College of New Jersey and an MBA from The Wharton School of the University of Pennsylvania.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 20/07/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| GRACE THERAPEUTICS, INC. | Director/Miembro de la Junta | 10/10/2023 |
Cortendo AB
 Cortendo AB Miscellaneous Commercial ServicesCommercial Services Pioneered cortisol inhibition as a treatment for Metabolic Syndrome | Director Financiero/CFO | 23/03/2015 |
Xylocor Therapeutics, Inc.
 Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel gene therapy for cardiovascular disease | Director Financiero/CFO | 01/01/2021 |
| Empresas | Cargo | Fin |
|---|---|---|
| VERRICA PHARMACEUTICALS INC. | Director Financiero/CFO | 16/07/2021 |
| STRONGBRIDGE BIOPHARMA | Director Financiero/CFO | 03/09/2019 |
| TENGION, INC. | Director Financiero/CFO | 31/12/2014 |
Neose Technologies, Inc.
 Neose Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic protein drugs | Director Financiero/CFO | 08/07/2010 |
MICRO Healthsystems, Inc.
 MICRO Healthsystems, Inc. Packaged SoftwareTechnology Services Operating systems computer software | Comptroller/Controller/Auditor | 01/01/1994 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 10 |
|---|---|
MICRO Healthsystems, Inc.
MICRO Healthsystems, Inc. Packaged SoftwareTechnology Services Operating systems computer software | Technology Services |
Neose Technologies, Inc.
Neose Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic protein drugs | Health Technology |
Tengion, Inc.
 Tengion, Inc. BiotechnologyHealth Technology Develops new human organs and tissues | Health Technology |
Grace Therapeutics, Inc.
 Grace Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for rare and orphan diseases | Health Technology |
Cortendo AB
Cortendo AB Miscellaneous Commercial ServicesCommercial Services Pioneered cortisol inhibition as a treatment for Metabolic Syndrome | Commercial Services |
The College of New Jersey
 The College of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Strongbridge Biopharma Plc
 Strongbridge Biopharma Plc Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for rare diseases | Health Technology |
Verrica Pharmaceuticals, Inc.
 Verrica Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Xylocor Therapeutics, Inc.
Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel gene therapy for cardiovascular disease | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
